Logo image
IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis
Journal article   Peer reviewed

IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis

W. Xu, R. li, Y. Dai, A. Wu, H. Wang, C. Cheng, W. Qiu, Z. Lu, X. Zhong, Y. Shu, …
Journal of Neuroimmunology, Vol.261(1-2), pp.87-91
2013
url
Link to Published Version *Subscription may be requiredView

Abstract

Interleukin (IL)-22 secreting CD4+ T (Th22) cells and IL-22 are involved in the pathogenesis of autoimmune disease, but their role in neuromyelitis optica (NMO) and multiple sclerosis (MS) is unclear. We measured the proportion of Th22, Th17, CD4+IL-22+IL-17A+ T cells and serum IL-22 in NMO and MS patients. The proportion of Th22 cells, Th17 cells and serum IL-22 were increased in patients with NMO and MS. Our findings suggest that increased Th22 cells may play an important role in the pathogenesis of NMO and MS.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.6 Immunology
1.6.487 Regulatory T Cells
Web Of Science research areas
Immunology
Neurosciences
ESI research areas
Neuroscience & Behavior
Logo image